J.P. Morgan analyst Jessica Fye has maintained their bullish stance on CRNX stock, giving a Buy rating yesterday.Stay Ahead of the ...

Marea’s Phase IIa study enrolled patients with hypertriglyceridemia—too much fat in the blood. The latest results showed the ...

Endocrinology specialist Dr Preethi Dissanayake discusses this uncommon presentation, in the latest in our series on ...

The following is a summary of “Knowledge and attitudes of primary care physicians regarding acromegaly: a survey study with ...